Speaker(s): 

Nicholas Flint, MD, Resident, Geisinger- has nothing to disclose.

Milie Fang, DO, Outside faculty Member, University of Washington, Seattle, WA  - has nothing to disclose.

Moderators:

Christen Mowad, MD, Staff Members, Geisinger - has nothing to disclose. 

Mickey Horissian, MD, Staff Member, Geisinger has disclosures:  UCB (Consultant/Advisor/Speakers Bureau), Bristol Myers-Squibb (Consultant/Advisor)

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Improve clinicopathologic correlation.
• Evaluate, diagnose and manage dermatologic conditions in hospitalized patients.
• Name the most common atopic dermatitis criteria, especially those used in epidemiological research.
• Summarize the important findings from the CASCADE trial
• Describe the benefits of pediatric tele dermatology
• Recognize the potential health inequities associated with pediatric tele dermatologyChr

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Eric Hossler, MD and Ashley Hubal, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose: Dean Parry, RPh and Sara Gaines, PharmD

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None